PRDX2 and neoplasm: This low reduction capacity of oxidized Prdx2 is a specific feature of erythrocytes and some other cells (e.g., hepatocytes), while the majority of tumor cell lines maintain the capacity for the reduction of oxidized Prdx2 in slight excess over the maximal steady-state Prdx2 oxidation [153].